ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PAMELA ARCHULETA NP

4696 W OVERLAND RD SUITE 236

Boise | Idaho | 83705

(208) 850-5516

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,732Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 85

$1.16M Total Retail Price of All Prescriptions

Rank: 2 out of 85

291 Patients Receiving at Least One Drug in Part D
8%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 291 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

12% of this provider’s 525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$133 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
RISPERIDONE 529 44 1 20
BENZTROPINE MESYLATE 467 37 R 2 21
SERTRALINE HCL 375 39 3 17
LAMOTRIGINE 352 26 4 16
FLUOXETINE HCL 352 34 4 24
ABILIFY 341 24 6 22
CITALOPRAM HBR 280 0 7 8
LITHIUM CARBONATE 266 0 8 37
HALOPERIDOL 259 11 9 50
CLONIDINE HCL 253 0 10 45
ZOLPIDEM TARTRATE 225 0 11 9
OLANZAPINE 222 40 12 28
HYDROXYZINE PAMOATE 214 13 R 13 58
RISPERDAL CONSTA 214 0 13 71
QUETIAPINE FUMARATE 207 0 15 31
PROPRANOLOL HCL 201 0 16 60
MIRTAZAPINE 194 0 17 46
BUPROPION XL 175 14 18 34
TRAZODONE HCL 167 18 19 13
TRIHEXYPHENIDYL HCL 166 0 R 20 65
DIVALPROEX SODIUM ER 165 0 21 38
CLOZAPINE 153 0 22 48
BUSPIRONE HCL 145 11 23 59
CYMBALTA 145 38 23 19
OXCARBAZEPINE 137 0 25 86
VENLAFAXINE HCL ER 136 17 26 44
TOPIRAMATE 126 0 27 61
PAROXETINE HCL 126 11 27 65
INVEGA 114 11 29 51
INVEGA SUSTENNA 95 0 30 52
SEROQUEL 78 0 31 74
GABAPENTIN 77 0 32 12
CLOMIPRAMINE HCL 77 0 R 32 102
CARBAMAZEPINE 76 0 34 87
STRATTERA 75 0 35 84
PRAZOSIN HCL 75 0 35 83
FLUPHENAZINE DECANOATE 75 0 35 105
FLUPHENAZINE HCL 71 0 38 89
ZIPRASIDONE HCL 70 0 39 72
GUANFACINE HCL 68 0 R 40 111
ZALEPLON 66 0 41 113
BUPROPION HCL SR 66 0 41 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.